Research at the top

Our university has 

Hepatitis C Risk Assessment test


Introduction:


More than 170 million of the world population is either suffering from (or is carrier of) Hepatitis C, a serious viral infection. Over four million Americans infected with Hepatitis C virus (HCV) leading to estimated 10000 deaths annually in the US alone, is a grave disease, about which these pages have been written. Estimated 1.8% of the US population has been infected, which is more then 3.5 times of HIV infection! Approximately 25000+ new cases are reported yearly in the US. Estimated 250000 people in Canada are HCV positive. About 250000 people in Australia are supposed to be infected with Hepatitis C virus. It strongly believed that the infection is spreading increasingly, principally due to ignorance and lack of precise treatment. These figures certainly call for serious and careful attention to this virus induced ailment. About 200 million people world over are infected with HCV infection. European countries seem to be harboring about 15 million patients with HCV, as per one study. Country wise statistical figures are not yet available, hence there is a likelihood of greater gravity of this disease then one can imagine. It is high time that this silent killer epidemic is well understood before it becomes pandemic.


What is Hepatitis C?:


Hepatitis means an inflammation of the liver. When the inflammation of the liver is due to a specific RNA virus which leads to chronic inflammation, it is called Hepatitis C. There are several virus names as A,B,C,D,E, etc. which are known to affect the liver, producing Hepatitis A, Hepatitis B, Hepatitis C, etc. In fact, this particular virus has a capacity to induce not only inflammation but scarring of the liver, which is called as cirrhosis of liver.The virus tends to multiply rapidly hence not allowing to developed natural antibodies in adequate quantity. This virus is a slow and silent destroyer of liver cell. It may so happen that one may not realize of the infection for years together.


After a prolonged state of inflammation cirrhosis may take place, which may take ten to fifty years. It is a very slow process, if not aggravated by certain food had habits and alcohol.


Hepatitis C carriers::


The carriers of Hepatitis C are believed to be about 0.3% in the US, about 0.1% in Europe, 0.5% in India, 4% in Egypt, 2% in Japan and estimated 1.5% in Africa.


How does one get Hepatitis C?:


The virus spreads through blood or infected syringes. (Similar to Hepatitis B and HIV infection.) Those who are drug addicts using syringes, frequent blood donors (not using sterile syringes) are prone to catch this virus. Tattooing and body piercing could be a source of infection. Organ transplant, dialysis for kidney failure are other important sources of infection. It is uncommon that one may get this virus through sexual contact. It is believed by most, today that steady partner may not need physical protection if one partner is Hepatitis C positive. However, unsafe sex with changing partners may prove to be a source of infection. It does not spread by touch, saliva, air, food or water. Mother to baby transmission during the birth is possible. However, the rate of such transmission is not significantly high.




Homoeopathy India Foundation

Hepatitis C Treatment Project

Homoeopathy India Foundation

203-A,Trimurty Arcade, LBS Road,

Ghatkopar West, Mumbai 400086. India

Tel.: 91-22-25119080 / Fax: 91-22-25114466


~ Life Force Clinic

2-B,Vaibhav, Tilak Road,

Ghatkopar East, Mumbai 400077. India

Tel.: 91-22-25131662 / 25093242

e-mail: info@e-hepatitis-c.com


Contact us

3,000 students graduate each year and find a job within 2 months

Join them and increase your chances to get hired.

Driven by Excellence



How to diagnose Hepatitis C?:


The clinical symptoms alone cannot determine the diagnosis of Hepatitis C. The diagnostic test for Hepatitis C is a study of certain Liver enzyme and Hepatitis C specific antibodies in the blood. Anti Hepatitis C (Anti HCV) virus antibodies can be detected in the blood after 3 to 6 weeks. It may be noted that Anti HCV may not be detected adequately during the acute phase of Hepatitis C. ELISA test for HCV antibody is an important diagnostic test to detect the HCV antibodies, which indicates exposure to the infection.


A.Antibody to Hepatitis C virus:



Enzyme immunoassay test (EIA): This test has to be carried out in the initial stage.

Recombinant Immunoblot Assay (RIBA): This an additional test to support and confirm the diagnosis if the EIA is positive.

Above tests will give a clue if one has an exposure to the infection. However, they cannot indicate the quantum or extent of infection. There are some quantitative tests to determine the amount of virus titer, that is HCV RNA.


B. The Quantitative test:


The quantitative tests to detect amount (titer) of virus (HCV RNA) are:  Amplicor HCV Monitor™

Quantiplex HCV RNA (bDNA)


It is important to note that the laboratory test as above may be false positive or false negative.


Liver biopsy is not done commonly as a diagnostic test. However, liver biopsy gives an idea about the extent of severity, of fibrosis and cirrhosis.


Differential Diagnosis:


While diagnosing the disease as Hepatitis C, the following conditions which resemble Hepatitis C, need to be ruled out:

Hepatitis B

Hepatitis D

Alcoholic hepatitis and Alcoholic Cirrhosis of liver

Auto immune hepatitis

Sclerosing cholangitis

Wilson's disease

Iatrogenic Liver disease (Drug induced)




Homoeopathy India Foundation

Hepatitis C Treatment Project

Homoeopathy India Foundation

203-A,Trimurty Arcade, LBS Road,

Ghatkopar West, Mumbai 400086. India

Tel.: 91-22-5119080 / Fax: 91-22-5114466


~ Life Force Clinic

2-B,Vaibhav, Tilak Road,

Ghatkopar East, Mumbai 400077. India

Tel.: 91-22- 5131662 / 5093242

e-mail: info@e-hepatitis-c.com


Learn more

12
Faculties
45
Nationalities
8
Libraries
16,456
Students

What makes us different?



Long term complications :


Hepatitis C being a chronic infection, it has certain long term complications. About 80% or more patients tend to develop chronic symptoms due to recurring or chronic liver inflammation. Many of the HCV infected patients suffer from recurring acute liver inflammation (acute hepatitis). About 10% patients develop cirrhosis (scarring) of liver, leading to diminished liver functions, within early 10 years. 25% of the patients develop cirrhosis eventually. About 5% of those infected may develop liver cancer.


Broadly, it may be noted that it takes one decade to develop early symptoms, about two decades to have cirrhosis, and above three decades to have cancer of the liver.


Liver cancer is a fatal condition.


The factors which could aggravate and influence early development of liver inflammation, cirrhosis and cancer, are:

(1.) Alcohol (2.) Smoking (3.) Liver toxic drugs (4.) Exposure to chemicals (5.) Stressful life style (6.) Hepatitis B infection (7.) Hereditary tendency to cirrhosis or cancer


Hepatitis C and associated disease conditons:


Hepatitis C and Lichen Planus:

Exact connection between the two has not been understood very well. Howver, the studies indicate that Lichen Planus is associated with Hepatitis C in several cases.


Hepatitis C is often found to be associated with Diabetes Mellitus. Patines with Hep C have increased pronesness to develope diabetes.


Cetain studies have shown Thyroid dysfuntions (Hypothyroid and hyperthyroidis) associated with Hepatitis C.

What will affect the future of Hepatitis C patients:

Females are knwn to have slow disease progress as compared to the male patients. Late age onset (after 40 yers of age) of Hepatitis C tends to run serius course of dieasese then the younger age group patients. Consuption of alcohol can increse teh risk factor severl follds once the diognosis of Hepatitis C is made, as alcohol has toxic action on the liver which can aggravet the scarring (cirrhosis) of liver.


Chronic sufferers after 20 to 25 years stand increwsed risk to develope Liver cancer, which is observed more in males, with increeased risk in higher (older) age group.


Homoeopathy India Foundation

Hepatitis C Treatment Project

Homoeopathy India Foundation

203-A,Trimurty Arcade, LBS Road,

Ghatkopar West, Mumbai 400086. India

Tel.: 91-22-5119080 / Fax: 91-22-5114466


~ Life Force Clinic

2-B,Vaibhav, Tilak Road,

Ghatkopar East, Mumbai 400077. India

Tel.: 91-22- 5131662 / 5093242

e-mail: info@e-hepatitis-c.com


Discover more

Programmes




The Hepatitis C Treatment Project (HCTP) has been undertaken by Homoeopathy India Foundation TM , to help the patients of Hepatitis C. In this global project, the cases are invited to participate from all over the world, during different stages of infection, living under different cultural environments. All the cases under this project will be treated with homeopathic medicines, simultaneous to other mode of treatment which may be used by the patients (if indicated). The cases will be studied, evaluated and treated with scientifically designed treatment protocol, under care of a team of experts. The cases will be monitored for a long period of time (about 10 to 30 years), evaluating different aspects of illness through the entire range of the infection, while offering homeopathic medicines during various stages, as required.


This project is not a commercial program.


Why this project


Homeopathy (=homoeopathy), a 206 years old alternative medicine is known for its role for the treatment of chronic diseases including chronic virus infection such as Hepatitis B & C. This treatment project, HCTP, has been launched by Homoeopathy India Foundation TM to offer the homeopathy benefit to the sufferers of Hepatitis C, world over, for a small cost. This project will also prove to be a platform for the patients, medical practitioners and the researchers to understand: 1.) Hepatitis C, as a disease 2.) Role of homeopathy for chronic infections.


Who can participate?


This treatment project invites patients (HCV positive) including silent carriers.


The features, terms and conditions of participation:


a. The Hepatitis Treatment Project is not a commercial program but a self-funded program, where the treatment is offered at a nominal cost to the patients residing anywhere in the world. The treatment cost covers the charges towards medicine, consultation as well as the shipping.


b. There is no need for the participant to visit us in person, at our centers.


c. The medicines will be sent to the patients by post or courier, from our center.


d. The participant may continue or may take any other mode of medicine in future. However, it is expected of the participant to keep us updated as to what kindly of medicines are being taken.


e. Detail history and feedback will be expected from the participant, time to time, to be able to help them better.


f. The participant will be right to discontinue with the participation in the treatment project.


g. Homeopathic medicine are absolutely safe and free from any side effects, even while using for a long period.


h. Homoeopathy India Foundation TM reserves the rights of admitting the participant to the course, and discontinue the participation, if the participant is not suitable to the project protocol.


i. No unknown medicines or trial medicines will be administered to the participants without due information.


j. The participant has to be over 18 years of age to take part in the project.


k. No claim is made by Homoeopathy India Foundation TM or by the doctors connected with the project, to cure Hepatitis C or its associated disease features.


l. Consequences, in terms of additional health related symptoms, should not be linked to the participation in the treatment project, and taking of the medicines. Homeopathic medicines in general and the medicines chosen for the project, are essentially safe and free from side effects. Homoeopathy India Foundation TM and the team of doctors take no responsibility whatsoever, of the side effects, if claimed to be that due to the homeopathic medicines.


m. Homoeopathy India Foundation TM reserves the rights to make required changes in the treatment protocol, time to time.


n. Your participation indicated that you agree to all the terms and conditions as stated above.


How to participate?


There are three treatment commitment plans for the patients to choose from:


Group 1 year 3 years 10 years

USA, Canada, Europe, South America, Caribbean countries US$ 120 US$ 250 US$ 500

Africa, Asia (other then Group III countries) US$ 90 US$ 150 US$ 400

India. Bangladesh, Sri Lanka, Pakistan, Bhutan (The residents only) Ind Rs.3000/- Not available Not available

Renewal (1 year) Renewal (3 years) Renewal (10 years)

USA, Canada, Europe, South America, Caribbean countries US$ 100 US$ 250 US$ 500

Africa, Asia (other then Group III countries) US$ 90 US$ 150 US$ 400

India. Bangladesh, Sri Lanka, Pakistan, Bhutan (The residents only) Ind Rs.3000/- Not available Not available



Please note that the charges include cost towards consultation, cost of the medicine and shipping of medicines, for the period chosen.



Want to participate           Do not want to participate



~



Contact if you have questions:


Homoeopathy India Foundation

Hepatitis C Treatment Project

Homoeopathy India Foundation

203-A,Trimurty Arcade, LBS Road,

Ghatkopar West, Mumbai 400086. India

Tel.: 91-22-5119080 / Fax: 91-22-5114466


~ Life Force Clinic

2-B,Vaibhav, Tilak Road,

Ghatkopar East, Mumbai 400077. India

Tel.: 91-22- 5131662 / 5093242


Administrative office in the US:

(for mailing subscription from within the US):

Homoeopathy India Foundation

410 Park Avenue, 15th Floor # 260pmb

New York, NY 10022 USA

Phone: (917) 210-8062

Fax: (917) 210-8182


e-mail: info@e-hepatitis-c.com 

More Details

The campus


The small and modern campus is only a 10-minute walk away from the city centre and is easily accessible by car and public transport. It is also close to the train stations.

More Details